Switching From Ozempic to Mounjaro — Labels, Questions, What to Log

Your A1C came back and your doctor says, "Let's try Mounjaro." You've been on Ozempic long enough to know your shot day by heart and roughly how the day after feels. Now there's a new pen, a new number on the box, and a quiet worry about whether your blood sugar will hold steady while you change.

That worry is reasonable. It's also exactly what a planned switch is designed to handle.

Why do people switch from Ozempic to Mounjaro?

A 2020 review of switching between GLP-1 medicines describes the usual reasons: blood sugar or weight goals not being met, side effects, a specific approved benefit, preference, and cost or coverage. It was written before tirzepatide arrived, but the reasons translate.

For Ozempic to Mounjaro, the most common driver is results. In the SURPASS-2 trial of adults with type 2 diabetes on metformin, all three Mounjaro doses lowered HbA1c more on average than Ozempic 1 mg over 40 weeks. That's a group average, and the trial didn't study people switching from one to the other.

Can't I just take the "same" dose of Mounjaro?

There isn't a same dose. Ozempic is semaglutide, which acts on the GLP-1 receptor. Mounjaro is tirzepatide, which acts on both the GIP and GLP-1 receptors. The labels describe each medicine on its own and give no conversion.

What do the labels say about starting each one?

	Ozempic (semaglutide)	Mounjaro (tirzepatide)
Standard start	0.25 mg weekly for 4 weeks	2.5 mg weekly for 4 weeks
What the start dose is for	Getting started; then 0.5 mg	Initiation only, "not intended for glycemic control"
How it steps up	To 1 mg, then 2 mg, after at least 4 weeks on each, if more control is needed	2.5 mg steps after at least 4 weeks, if more control is needed
Maximum	2 mg weekly	15 mg weekly in adults
Missed dose	Within 5 days, otherwise skip	Within 4 days, otherwise skip

Both labels say the gradual escalation is there to reduce stomach side effects.

Why might my prescriber start me low?

Because a new molecule is new to your stomach, even if the old one had settled. The 2020 review notes that moving straight to a higher dose of a new GLP-1 medicine can bring nausea and stomach upset, and that people who weren't tolerating their current dose should start the new one at its lowest dose.

The trade-off is that Mounjaro's starting dose isn't meant to control blood sugar. Your prescriber weighs that against side effects, your other medicines and your recent readings. Ask how they're balancing it for you, and what glucose numbers should prompt a call.

What else changes with Mounjaro?

Low blood sugar risk with other medicines. Both labels say that combining these medicines with insulin or a sulfonylurea raises the risk of hypoglycemia, and that lowering those doses may be considered. Ask whether your other diabetes medicines need adjusting.

Contraception. The Mounjaro label says it may make oral hormonal birth control less effective, especially after the first dose. It advises switching to a non-oral method, or adding a barrier method, for 4 weeks after starting and for 4 weeks after each dose increase. The Ozempic label has no such advice, so this is new.

The pen and the routine. New device, new instructions, slightly different missed-dose window. Read the Instructions for Use before your first shot, even if injecting feels routine.

What should I ask before the switch?

• When do I take my last Ozempic dose and my first Mounjaro dose?
• What dose will I start on, and how will we decide on the next step?
• How often should I check my glucose in the first weeks?
• Do my insulin or other diabetes medicines need to change?
• Which side effects mean I should call rather than wait?

What we'd track

1. Last Ozempic and first Mounjaro dose. Dates and strengths. It's the line everything else is compared against.
2. Side effects for the first weeks. Nausea, constipation, heartburn and fatigue, rated daily, especially in the days after each shot.
3. Glucose readings, if you check them. Your prescriber needs to see how the starting dose is doing on blood sugar, not just how it feels.
4. Appetite and meals. Changes in hunger show up quickly, and low intake can matter if you're also on insulin.
5. Weight trend. Weekly, not daily, across both medicines.

When your prescriber switches you, change the medication in Holt to Mounjaro. Your Ozempic doses stay in your dose history, with strength, site and date, so both medicines sit in one record. Side effects line up against dose days, and weight syncs with Apple Health.

Log your switch to Mounjaro in Holt

Keep your glucose readings in your meter's app or logbook, and bring them to your follow-up alongside Holt's doctor-visit report. Together they show how the new medicine is going from both sides.